Skip to main content
Fig. 7 | Breast Cancer Research

Fig. 7

From: Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low

Fig. 7

Different expression patterns of critical immunotherapeutic biomarkers in HER2low TNBC and HER2neg TNBC. (A) Violin plot shows the expression levels of key immunotherapeutic biomarkers in the two TNBC groups. See Additional file 14: Table S7 for details. (B) Color-coded UMAPs for expression levels (gray to red) of PDCD1 and CD274 in two TNBC groups. (C) Correlations between ERBB2 expression and immunotherapeutic targets (CD274, CTLA4, CD47, CDK6, DDR2, PDCD1), using Spearman correlation analysis; P < 0.05 indicates statistical significance

Back to article page